Study Analyzes Antiretroviral Drug Production
"Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment," PLoS Medicine: The study, conducted by Amy Nunn of the Harvard School of Public Healthand colleagues, analyzes the costs of individual antiretroviral drugsin Brazil, finding that although generic drugs produced in Brazil oftenare more expensive than similar drugs produced in other countries,Brazil still offers lower prices for patented antiretrovirals thanother developing countries.
Brazil produces eight genericantiretrovirals, and since 2001 it has negotiated antiretroviral priceswith five pharmaceutical companies, according to the study. The studyconcludes that although Brazil saved about $1 billion from 2001 to 2005on antiretrovirals through its strategies, drug costs continued toincrease as more people required treatment and HIV-positive peoplelived longer (PLoS Medicine release, 11/12).
Reprinted with permission from kaisernetwork.org. You can view theentire Kaiser DailyHIV/AIDS Report, search the archives, and sign up for email delivery at kaisernetwork.org/email . The Kaiser Daily HIV/AIDS Report ispublished for kaisernetwork.org, a free service of The Henry J. Kaiser FamilyFoundation.